Jean‐Louis Hébert

9.8k citations
144 papers · 4.8k indexed · 1 hit paper · h-index 31
Topics
Allergic Rhinitis and Sensitization (30 papers)Asthma and respiratory diseases (24 papers)Cardiomyopathy and Myosin Studies (14 papers)
Partner nations
FranceCanadaBelgium

In The Last Decade

Jean‐Louis Hébert

138 papers receiving 4.6k citations

Hit Papers

Benefits of omalizumab as add‐on therapy in patients with...20042026201120182004250500750

Peers

Jean‐Louis Hébert
Comparison fields: 5 of 138
  • Physiology 2.0k
  • Pulmonary and Respiratory Medicine 1.8k
  • Cardiology and Cardiovascular Medicine 1.3k
  • Immunology and Allergy 1.3k
  • Surgery 610
Replace Robin J. McAnulty with:
Robin J. McAnulty United Kingdom
Robin N. Poston United Kingdom
Gregory P. Geba United States
Hideaki Morita Japan
S.T. Holgate United Kingdom
Nunzio Crimi Italy
Martha L. Warnock United States
Takao Kobayashi Japan
Caroline A. Owen United States
Benjamin D. Medoff United States
Jean‐Louis Hébert relative to Robin J. McAnulty United Kingdom Robin J. McAnulty's profile →
Citations per field
00.5×5.1×
Robin J. McAnulty · 1×
Citations per year

Countries citing papers authored by Jean‐Louis Hébert

Since Specialization
Citations

This map shows the geographic impact of Jean‐Louis Hébert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Louis Hébert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Louis Hébert more than expected).

Fields of papers citing papers by Jean‐Louis Hébert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Louis Hébert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Louis Hébert. The network helps show where Jean‐Louis Hébert may publish in the future.

Co-authorship network of co-authors of Jean‐Louis Hébert

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Louis Hébert. A scholar is included among the top collaborators of Jean‐Louis Hébert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Louis Hébert. Jean‐Louis Hébert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 3
3 7
4 17
5 20
6 21
7 26
8 6
9
Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATEbreakdown →
839
10 21
11
La dysplasie ventriculaire droite
0
12 5
13 9
14 14
15 52
16 7
17 41
18 36
19
[Hypertrophic myocardiopathy with isolated obstruction of the right ventricle].
5
20
Behçet's disease: possible role of secretory component deficiency, synovial inclusions, and fibrinolytic abnormality in the various manifestations of the disease.
20

About Jean‐Louis Hébert

Jean‐Louis Hébert is a scholar working on Immunology and Allergy, Cardiology and Cardiovascular Medicine and Microbiology, having authored 144 papers that have together received 4.8k indexed citations. Recurring topics across this work include Allergic Rhinitis and Sensitization (30 papers), Asthma and respiratory diseases (24 papers) and Cardiomyopathy and Myosin Studies (14 papers). The work is most often cited by research in Immunology and Allergy (1.3k citations), Physiology (2.0k citations) and Cardiology and Cardiovascular Medicine (1.3k citations). Jean‐Louis Hébert has collaborated with scholars based in France, Canada and Belgium. Frequent co-authors include Yves Lecarpentier, D. S. Chemla, Marc Humbert, Jean Bousquet, Catherine Coirault, Alexandre Vallée, Karen Zamani, Martin Blogg, Jon G. Ayres and Raymond G. Slavin. Their work appears in journals such as Circulation, The Journal of Experimental Medicine and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026